Browsing by Author Baran, Yusuf

Showing results 108 to 127 of 173 < previous   next >
Issue DateTitleAuthor(s)
Feb-2016A molecular and biophysical comparison of macromolecular changes in imatinib-sensitive and imatinib-resistant K562 cells exposed to ponatinibKartal Yandım, Melis; Ceylan, Çağatay ; Elmas, Efe; Baran, Yusuf 
Jul-2016Molecular mechanisms of drug resistance and its reversal in cancerKartal Yandım, Melis; Adan Gökbulut, Aysun ; Baran, Yusuf 
Aug-2014Molecular mechanisms of quercitrin-induced apoptosis in non-small cell lung cancerÇinçin, Zeynep Birsu; Ünlü, Miray ; Kıran, Bayram; Bireller, Elif Sinem; Baran, Yusuf ; Çakmakoğlu, Bedia
2014Multidrug resistance in chronic myeloid leukemiaÜnlü, Miray ; Kiraz, Yağmur ; Kacı, Fatma Necmiye; Özcan, Mehmet Ali; Baran, Yusuf 
Feb-2009Multidrug resistance mediated by MRP1 gene overexpression in breast cancer patientsAbaan, Ogan Demir; Mutlu, Pelin Kaya; Baran, Yusuf ; Atalay, Can; Gündüz, Ufuk
2012A natural product, quercetin enhances the cytotoxic and apoptotic effects of dexamethasone on jurkat cellsBaran, Yusuf ; Kartal, Melis; Kozanoğlu, İlknur
Feb-2013New indication for therapeutic potential of an old well-known drug (propranolol) for multiple myelomaKozanoğlu, İlknur; Kartal Yandım, Melis; Çinçin, Zeynep Birsu; Özdoğu, Hakan; Çakmakoğlu, Bedia; Baran, Yusuf 
Oct-2015Nilotinib does not alter the secretory functions of carotid artery endothelial cells in a prothrombotic or antithrombotic fashionKatgı, Abdullah; Sevindik, Ömer Gökmen; Adan Gökbulut, Aysun ; Özsan, Güner Hayri; Yüksel, Faize; Solmaz, Şerife Medeni; Alacacıoğlu, İnci; Özcan, Mehmet Ali; Demirkan, Fatih; Baran, Yusuf ; Pişkin, Özden
Feb-2010Nilotinib significantly induces apoptosis in imatinib resistant K562 cells with wild-type BCR-ABL, as effectively as in parental sensitive counterpartsEkiz, Hüseyin Atakan ; Can, Geylani; Gündüz, Ufuk; Baran, Yusuf 
2009Nilotinib significantly induces apoptosis in imatinib resistant K562 cells, as effectively as in parental sensitive counterpartsBaran, Yusuf ; Can, Geylani; Ekiz, Hüseyin Atakan 
2012A novel agent, KL-21, has significant anticancer potential on chronic lymphocytic leukemia cells but not on healthy cellsBaran, Yusuf ; Gökbulut, Aysun ; Yaşar, M.
Jan-2013Novel agents targeting bioactive sphingolipids for the treatment of cancerAdan Gökbulut, Aysun ; Kartal Yandım, Melis; İskender, Güniz; Baran, Yusuf 
2014A novel biomarker for drug resistance in chronic myeloid leukemia: MicroRNA-17Baran, Yusuf ; Fıratlıgil, Burcu ; Kartal Yandım, Melis; Kiraz, Yağmur ; Kozanoğlu, İlknur; Özdoğu, Hakan; Ünal, Ali
Nov-2011A novel mechanism of dasatinib-induced apoptosis in chronic myeloid leukemia; ceramide synthase and ceramide clearance genesGencer, Emel Başak; Ural, Ali Uğur; Avcu, Ferit; Baran, Yusuf 
2010A novel mechanism of nilotinib-induced apoptosis; bioactive sphingolipidsBaran, Yusuf ; Camgöz, Aylin; Gençer, Emel; Ural, Ali; Avcu, Ferit
2015A novel natural product, KL-21, inhibits proliferation and induces apoptosis in chronic lymphocytic leukemia cellsAdan Gökbulut, Aysun ; Yaşar, Mustafa; Baran, Yusuf 
2008Optimization of transfection of green fluorescent protein in pursuing mesenchymal stem cells in vivoBaran, Yusuf ; Ural, Ali Uğur; Avcu, Ferit; Sarper, Meral; Elçi, Pınar; Pekel, Aysel
Apr-2022Peptıde targeted core cross-lınked mıcelles for dox delıvery to HER2 expressıng cancer cellsBayram, Nazende Nur; Ulu, Gizem Tuğçe ; Gürdap, Seda; İşoğlu, İsmail Alper; Baran, Yusuf ; Dinçer İşoğlu, Sevil
Nov-2015The pleiotropic effects of fisetin and hesperetin on human acute promyelocytic leukemia cells are mediated through apoptosis, cell cycle arrest, and alterations in signaling networksAdan, Aysun ; Baran, Yusuf 
2013Ponatinib regulates major signaling pathways in imatinib-resistant chronic myeloid leukemia cellsAvcı, Çığır Biray; Kayabaşı, Çağla; Yılmaz Süslüer, Sunde; Balcı, Tuğçe; Saydam, Güray; Baran, Yusuf ; Gündüz, Cumhur